SEO URLwww.firestrike.ai/deals/sciwind-biosciences-pfizer-acquisition-2026
acquisitionAnnounced · Feb 24, 2026PharmaceuticalsSource · CredibleArticle · Factual
Pfizer acquires Sciwind Biosciences
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$495M
Target
Sciwind Biosciences
San Ramon, California
Acquirer
Pfizer
Financial Stake
Status
Announced
Pfizer agreed to acquire Sciwind Biosciences. Reported deal value: $495M. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: San Ramon, California, United States.
This page summarizes publicly available information about the transaction as of 2026-02-24. Figures and status may change as filings and press coverage update.
Pfizer in diabetes drug deal with Sciwind Biosciences
Deal timeline
Announced
Feb 24, 2026 · economictimes.indiatimes.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $495M. Figures and status may change as sources update.
Sources: economictimes.indiatimes.com · Primary article · FireStrike proprietary index